Research Video Series - FDA Approval of INGREZZA
October 06, 2023
HDYO has more information about HD available for young people, parents and professionals on our site:
www.hdyo.org
Drug to treat movement symptoms of HD approved by FDA
This installment of HDYO Research Video Series focuses on the recent HD Buzz article focusing on the recent FDA approval of INGREZZA to treat movement symptoms in Huntington's Disease.
To read the complete article, visit https://en.hdbuzz.net/348
The Research Video Series is sponsored by Teva Pharmaceutical, uniQure, The Griffin Foundation, Neurocrine Biosciences, Sage Therapeutics and Roche.